am-1714 am-1714 am-1714 (part of the am cannabinoid series) is a drug that acts as a reasonably selective agonist of the peripheral cannabinoid receptor cb2, with sub-nanomolar affinity and 490x selectivity over the related cb1 receptor. in animal studies it has both analgesic and anti-allodynia effects. the 9-methoxy derivative am-1710 has similar cb2 affinity but only 54x selectivity over cb1. am-1714legal statuslegal status in general: uncontrolled identifiers iupac name 1,9-dihydroxy-3-(2-methyloctan-2-yl)-6h-benzochromen-6-one cas number335371-37-4pubchem cid9950486chemspider8126097 yuniie3oy6pcu04chemical and physical dataformulac22h26o4molar mass354.446 g·mol−13d model (jsmol)interactive image smiles o=c(o1)c2=c(c=c(o)c=c2)c3=c1c=c(c(c)(c)cccccc)c=c3o inchi inchi=1s/c22h26o4/c1-4-5-6-7-10-22(2,3)14-11-18(24)20-17-13-15(23)8-9-16(17)21(25)26-19(20)12-14/h8-9,11-13,23-24h,4-7,10h2,1-3h3key:bwkbveveqocscf-uhfffaoysa-n